Peicheng Li
- Molecular Biology
- Physiology
- Endocrinology, Diabetes and Metabolism top 10%
- Neurology top 10%
- Epidemiology
- Co-authors
- Zhaosheng TangLin WangBo FengXinfeng YanJie DingGao‐Jun TengXiqi ZhuYu Wang
- Topics
- Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers)Acute Ischemic Stroke Management (4 papers)Diabetes Treatment and Management (4 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Peicheng Li
29 papers receiving 751 citations
Peers
Comparison fields: 5 of 97
- Molecular Biology 342
- Physiology 149
- Endocrinology, Diabetes and Metabolism 148
- Neurology 119
- Epidemiology 111
Countries citing papers authored by Peicheng Li
This map shows the geographic impact of Peicheng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peicheng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peicheng Li more than expected).
Fields of papers citing papers by Peicheng Li
This network shows the impact of papers produced by Peicheng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peicheng Li. The network helps show where Peicheng Li may publish in the future.
Co-authorship network of co-authors of Peicheng Li
This figure shows the co-authorship network connecting the top 25 collaborators of Peicheng Li. A scholar is included among the top collaborators of Peicheng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peicheng Li. Peicheng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 24 | |
| 6 | 32 | |
| 7 | 23 | |
| 8 | 20 | |
| 9 | 8 | |
| 10 | 6 | |
| 11 | 0 | |
| 12 | 24 | |
| 13 | 7 | |
| 14 | 40 | |
| 15 | 129 | |
| 16 | 30 | |
| 17 | 26 | |
| 18 | 13 | |
| 19 | 39 | |
| 20 | 21 |
About Peicheng Li
Peicheng Li is a scholar working on Hepatology, Endocrinology, Diabetes and Metabolism and Clinical Biochemistry, having authored 31 papers that have together received 761 indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Acute Ischemic Stroke Management (4 papers) and Diabetes Treatment and Management (4 papers). The work is most often cited by research in Neurology (119 citations), Endocrinology, Diabetes and Metabolism (148 citations) and Clinical Biochemistry (55 citations). Peicheng Li has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Zhaosheng Tang, Lin Wang, Bo Feng, Xinfeng Yan, Jie Ding, Bo Feng, Gao‐Jun Teng, Xiqi Zhu, Yu Wang and Lei Xu. Their work appears in journals such as PLoS ONE, Scientific Reports and Brain Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.